26 min listen
Subcutaneous Versus Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies - A Meta-Analysis
FromAmerican Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
Subcutaneous Versus Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies - A Meta-Analysis
FromAmerican Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
ratings:
Length:
15 minutes
Released:
Jun 27, 2018
Format:
Podcast episode
Description
Dr. Speelziek interviews Dr. Kurt Kimpinski and Dr. Luciano Sposato on their article, Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies. A meta-analysis. High-dose intravenous immunoglobulin (IVIg) is an evidence-based treatment for multifocal motor neuropathy (MMN) and chronic inflammatory demyelinating polyneuropathy (CIDP). Recently, subcutaneous immunoglobulin (SC-Ig) has received increasing attention. The authors performed a meta-analysis of reports of efficacy and safety of SC-Ig versus IVIg for inflammatory demyelinating polyneuropathies.The efficacy of SC-Ig is similar to IVIg for CIDP and MMN and has a significant safety profile. Muscle Nerve 55: 802-809, 2017.
Released:
Jun 27, 2018
Format:
Podcast episode
Titles in the series (100)
Is Exercise Necessary with Repetitive Nerve Stimulation in Evaluating Patients with Suspected Myasthenia Gravis by American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)